SOURCE: Vet-Stem

dog arthritis, dog stem cell, stem cell, arthritis

March 16, 2011 14:22 ET

Confirmation of Vet-Stem Exclusive Rights to Veterinary Use of Adipose Stem Cells

POWAY, CA--(Marketwire - March 16, 2011) - The Federal Appeals Court has clearly ruled that Vet-Stem's licensors, The University of Pittsburgh and Artecel, Inc. are the exclusive inventors of the adipose stem cell, specifically in the patent 6,777,231. The headline is "COURT DETERMINES THAT UNIVERSITY OF PITTSBURGH AND ARTECEL HAVE SOLE RIGHTS TO ADIPOSE-DERIVED STEM CELL PATENT." Artecel, Inc. is the human stem cell company that holds all of the rights to this patent portfolio and they have licensed all of the veterinary rights globally to Vet-Stem. To make clear, here is the statement from Linda Powers, the Chairman of the Board of Artecel:

January 1, 2011

To All Concerned parties:

This letter is to clarify the veterinary rights to the University of Pittsburg patent portfolio surrounding the 6,777,231 patent and the portfolio of Artecel patents related to adipose stem cell therapy and technology.  The University of Pittsburgh has exclusively licensed all of the human and veterinary fields of use of this portfolio to our corporation, Artecel, Inc.  Artecel has, in turn, exclusively licensed the global veterinary rights to the commercial company Vet-Stem, Inc. in Poway, California.

To make clear, Vet-Stem, Inc. has the exclusive worldwide veterinary license rights to this portfolio.  Neither Artecel nor the University of Pittsburg has licensed any of these veterinary rights to other parties inside or outside the United States.  Any inquiries regarding veterinary stem cell therapy that relate to this patent portfolio should be directed to the management of Vet-Stem, Inc (www.vet-stem.com, 858-748-2004).

Sincerely,

Linda F. Powers
Chairman

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. Vet-Stem has exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells.

Contact Information

  • For additional information, contact:
    Michael Dale
    COO, VP Sales and Marketing
    Vet-Stem, Inc
    12860 Danielson Court, Suite B
    Poway, CA 92064
    858-748-2004
    http://www.vet-stem.com
    Email Contact